Efinaconazole

규격

164650-44-6CAS 번호

813-597-5EC 번호

(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-olIUPAC 명칭

C18H22F2N4O화학식

348.4 g/mol분자량

EFINACONAZOLE; 164650-44-6; (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; JUBLIA; KP-103; efinaconazol; Clenafin; KP103; Kp 103; efinaconazolum; IDP-108; J82SB7FXWB; CHEBI:82718; (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol; 1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaR)-; DTXSID40167787; (2R,3R)-2-(2,4-Difluorofenil)-3-(4-metilenopiperidin-1-il)-1-(1H-1,2,4-triazin-1-il)butan-2-ol; RefChem:57013; DTXCID3090278; D01AC19; 813-597-5; MFCD00936406; 164905-19-5; C18H22F2N4O; (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol; (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidyl)-1-(1,2,4-triazol-1-yl)butan-2-ol; (alphaR,betaR)-alpha-(2,4-Difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; Efinaconazole [INN]; UNII-J82SB7FXWB; Efinaconazole [USAN:INN]; Clenafin (TN); Jublia (TN); EfinaconazoleKP-103; Efinaconazole(KP-103); Efinaconazole; KP-103; RA6GZ65VVN; EFINACONAZOLE [MI]; EFINACONAZOLE [JAN]; EFINACONAZOLE [USAN]; Epitope ID:1398132; EFINACONAZOLE [VANDF]; SCHEMBL300738; EFINACONAZOLE [WHO-DD]; orb1223249; CHEMBL2103877; Efinaconazole (JAN/USAN/INN); SCHEMBL29858056; HSDB 8341; NFEZZTICAUWDHU-RDTXWAMCSA-N; EFINACONAZOLE [ORANGE BOOK]; EX-A2643; Efinaconazole, (alphaR,betaR)-rel-; EBC-26683; AKOS027323571; CCG-268012; CS-3500; DB09040; FD58714; NCGC00390702-01; NCGC00390702-02; NCGC00390702-03; AC-30630; AS-30126; HY-15660; SY245147; NS00068121; D10021; EN300-7393023; F466806; Q21011225; (2R, 3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidyl)-1-(1,2,4-triazolyl)butan-2-ol; (?R,?R)-?-(2,4-Difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; (|_R,|_R)-|_-(2,4-Difluorophenyl)-|_-methyl-4-methylene-|_-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol; (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol; (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidino)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; 1-PIPERIDINEETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.BETA.-METHYL-4-METHYLENE-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, (R-(R*,R*))-; 1-PIPERIDINEETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.BETA.-METHYL-4-METHYLENE-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-,(.ALPHA.R,.BETA.R)-; 1-Piperidineethanol, |A-(2,4-difluorophenyl)-|A-methyl-4-methylene-|A-(1H-1,2,4-triazol-1-ylmethyl)-, (|AR,|AR)-; 1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1- ylmethyl)-, (alphaR,betaR)-; 1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaR)-rel-; 1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R*,R*)-; 1-Piperidineethanol, alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R*,R*)-(+/-)-; rel-(alphaR,betaR)-alpha-(2,4-Difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol동의어